We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$999B
AUM Growth
+$24.7B
Cap. Flow
-$14B
Cap. Flow %
-1.41%
Top 10 Hldgs %
24.27%
Holding
2,908
New
248
Increased
1,171
Reduced
1,334
Closed
66

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$3.3B
2
LLY icon
Eli Lilly
LLY
+$2.75B
3
AZN icon
AstraZeneca
AZN
+$1.98B
4
CPNG icon
Coupang
CPNG
+$1.54B
5
FTNT icon
Fortinet
FTNT
+$1.48B

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$2.34B
2
MS icon
Morgan Stanley
MS
+$2.26B
3
ABNB icon
Airbnb
ABNB
+$2.04B
4
QCOM icon
Qualcomm
QCOM
+$1.95B
5
NVDA icon
NVIDIA
NVDA
+$1.81B

Sector Composition

Rank Sector Weight
1 Technology 23.35%
2 Healthcare 16.19%
3 Consumer Discretionary 15.55%
4 Financials 12.84%
5 Communication Services 12.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXTC icon
2751
NextCure
NXTC
$37.4M
$124K ﹤0.01%
1,033
+1
+0.1% +$145
IVAC
2752
DELISTED
Intevac Inc
IVAC
$124K ﹤0.01%
17,310
+34
+0.2% +$227
CLSD
2753
DELISTED
Clearside Biomedical
CLSD
$123K ﹤0.01%
+3,307
New +$166K
ADXS
2754
DELISTED
Advaxis Inc
ADXS
$123K ﹤0.01%
166,748
-233,700
-58% -$191K
NOVN
2755
DELISTED
Novan, Inc. Common Stock
NOVN
$121K ﹤0.01%
+7,780
New +$117K
PGEN icon
2756
Precigen
PGEN
$2.45B
$120K ﹤0.01%
17,415
-10,464
-38% -$88.5K
BTU icon
2757
Peabody Energy
BTU
$3.01B
$116K ﹤0.01%
+37,962
New +$143K
PED icon
2758
PEDEVCO
PED
$150M
$114K ﹤0.01%
+3,905
New +$126K
ATRS
2759
DELISTED
Antares Pharma, Inc.
ATRS
$113K ﹤0.01%
27,548
+16,312
+145% +$70.7K
STXS icon
2760
Stereotaxis
STXS
$139M
$111K ﹤0.01%
+16,449
New +$97.6K
LMACU
2761
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
$108K ﹤0.01%
+10,040
New +$122K
SBBP
2762
DELISTED
Strongbridge Biopharma plc.
SBBP
$108K ﹤0.01%
+38,951
New +$118K
PAYS icon
2763
Paysign
PAYS
$723M
$106K ﹤0.01%
+24,158
New +$115K
AGEN
2764
Agenus
AGEN
$311M
$104K ﹤0.01%
1,950
+32
+2% +$2.31K
LCTX icon
2765
Lineage Cell Therapeutics
LCTX
$278M
$103K ﹤0.01%
+43,800
New +$105K
ENLC
2766
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$103K ﹤0.01%
+23,923
New +$103K
SONN
2767
DELISTED
Sonnet BioTherapeutics
SONN
$101K ﹤0.01%
+18
New +$114K
ASPS icon
2768
Altisource Portfolio Solutions
ASPS
$64.5M
$100K ﹤0.01%
1,360
+3
+0.2% +$250
DDMX
2769
DELISTED
DD3 Acquisition Corp. II Class A Common Stock
DDMX
$100K ﹤0.01%
+10,212
New +$103K
WVVI icon
2770
Willamette Valley Vineyards
WVVI
$11.5M
$98K ﹤0.01%
10,850
CND
2771
DELISTED
Concord Acquisition Corp.
CND
$98K ﹤0.01%
+10,000
New +$100K
CTIC
2772
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$95K ﹤0.01%
+32,700
New +$107K
UAVS icon
2773
AgEagle Aerial Systems
UAVS
$55.5M
$94K ﹤0.01%
15
-10
-40% -$93.7K
LOTZ
2774
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$92K ﹤0.01%
+12,900
New +$125K
KODK icon
2775
Kodak
KODK
$992M
$91K ﹤0.01%
11,505
-105
-0.9% -$957

Similar funds

T. Rowe Price Associates's Q1 2021 Portfolio in Review

As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
  • T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
  • T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
  • T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
  • T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
  • T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
  • T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.